Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Einat, Hertzberg-Bigelman"'
Autor:
Michal Entin-Meer, Lena Cohen, Einat Hertzberg-Bigelman, Ran Levy, Jeremy Ben-Shoshan, Gad Keren
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177132 (2017)
We have recently shown that the expression of the transient receptor potential vanilloid 2 channel, TRPV2, is upregulated in the peri-infarct zone 3-5 days following an acute myocardial infarction (AMI). Further analysis has demonstrated that invadin
Externí odkaz:
https://doaj.org/article/a973126403ad465cb97a885bd13a0f81
Autor:
Lena Cohen, Ran Levy, Gad Keren, Einat Hertzberg-Bigelman, Jeremy Ben-Shoshan, Michal Entin-Meer
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 5, p e0177132 (2017)
PLoS ONE, Vol 12, Iss 5, p e0177132 (2017)
Background We have recently shown that the expression of the transient receptor potential vanilloid 2 channel, TRPV2, is upregulated in the peri-infarct zone 3–5 days following an acute myocardial infarction (AMI). Further analysis has demonstrated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5481b643bd4f92c7abf0f823803a3406
https://pubmed.ncbi.nlm.nih.gov/28481959
https://pubmed.ncbi.nlm.nih.gov/28481959
Autor:
Einat, Hertzberg-Bigelman, Rami, Barashi, Ran, Levy, Lena, Cohen, Jeremy, Ben-Shoshan, Gad, Keren, Michal, Entin-Meer
Publikováno v:
The Israel Medical Association journal : IMAJ. 18(6)
Chronic kidney disease (CKD) is often accompanied by impairment of cardiac function that may lead to major cardiac events. Erythropoietin (EPO), a kidney-produced protein, was shown to be beneficial to heart function. It was suggested that reduced EP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b956c9aa179c55c2862199f140d46c0e
https://pubmed.ncbi.nlm.nih.gov/27468524
https://pubmed.ncbi.nlm.nih.gov/27468524
Autor:
Michal Entin-Meer, Jeremy Ben-Shoshan, Gilad Margolis, Einat Hertzberg-Bigelman, Ran Levy, Gad Keren
Publikováno v:
Cardiology. 134(1)
Objectives: We aimed to examine the effects of colchicine, currently in clinical trials for acute myocardial infarction (AMI), on the viability of cardiac cells using a cell line model of AMI. Methods: HL-1, a murine cardiomyocyte cell line, and H9C2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6060e8216d1a20189d9e8c3b9252541b
https://pubmed.ncbi.nlm.nih.gov/26882242
https://pubmed.ncbi.nlm.nih.gov/26882242
Autor:
Entin-Meer, Michal1,2 michale@tlvmc.gov.il, Cohen, Lena1,2, Hertzberg-Bigelman, Einat1,2, Levy, Ran1, Ben-Shoshan, Jeremy1,2, Keren, Gad1,2
Publikováno v:
PLoS ONE. 5/8/2017, Vol. 12 Issue 5, p1-17. 17p.
Autor:
Hertzberg-Bigelman, Einat, Barashi, Rami, Levy, Ran, Cohen, Lena, Ben-Shoshan, Jeremy, Keren, Gad, Entin-Meer, Michal
Publikováno v:
Israel Medical Association Journal; Jun2016, Vol. 18 Issue 6, p326-330, 5p
Autor:
Margolis, Gilad, Hertzberg-Bigelman, Einat, Levy, Ran, Ben-Shoshan, Jeremy, Keren, Gad, Entin-Meer, Michal
Publikováno v:
Cardiology; Apr2016, Vol. 134 Issue 1, p57-64, 8p, 5 Graphs
Autor:
Rofe, May-Tal, Levi, Ran, Hertzberg-Bigelman, Einat, Goryainov, Pavel, Barashi, Rami, Ben-Shoshan, Jeremy, Keren, Gad, Entin-Meer, Michal
Publikováno v:
Israel Medical Association Journal; Dec2015, Vol. 17 Issue 12, p744-749, 6p